The Pharmaceutical Division of SMC Enterprise Ltd started its journey in August 2017 with the key objective of “No one should suffer, especially the less-privileged due to lack of affordable quality medicine.” The slogan that will drive SMC’s pharmaceutical business is “providing quality medicine for all” irrespective of socio-economic status and ability to pay. It promotes 18 products in the market which includes anti-ulcerant, NSAIDs, anti-histamine, anti-asthmatic, anti-spasmodic and mineral supplement. These drugs belong to both the OTC category as well as the selective therapeutic class. In July 2018, SMC Pharmaceutical Division launched three new products:

●  SMC Zinc Syrup (To enhance growth, develop brain function and improve immune system)

●  Moticare (For the treatment of nausea, vomiting, gas and bloating, postprandial fullness, GERD, heartburn, etc.)

●  Kofmelt Syrup (For the treatment of cough with mucus)

With the philosophy “profit must primarily contribute to social betterment” our pharma division is taking all initiatives to fulfill the objective.